InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

SHERMAN JEFFREY W · Director — personal trades · 25 reports

← Executives ★ Sign in to follow

SJ

SHERMAN JEFFREY W

Director

BoardM

USUS·SEC (Form 4)

Strongbridge Biopharma plc Strongbridge Biopharma plc Horizon Therapeutics Public Ltd Co Xeris Biopharma Holdings, Inc.

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€4m

▼ Sales (1 ops.)

Discover the complete record of transactions filed by SHERMAN JEFFREY W, Director. Insider active across 4 companies, notably Strongbridge Biopharma plc. Cumulatively, 25 disclosures have been recorded. Total volume traded: €4.2m. The latest transaction was filed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.

Declarations25 total

Executives◆GrantXXeris Biopharma Holdings, Inc.11SEC

S

SHERMAN JEFFREY WDirector

015,000 shares0

Common Stock

SEC:0001867096-22-000095:0·8 Jun 2022

Executives▼SaleHHorizon Therapeutics Public Ltd Co37SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

€4m42,009 shares@ €100.953196.8% of flow

Ordinary Shares

SEC:0001209191-22-023841:0·6 Apr 2022

Executives●DonHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

012,304 shares0

Ordinary Shares

SEC:0001209191-22-020259:0·25 May 2021

Executives◇OptionsHHorizon Therapeutics Public Ltd Co9SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

05,354 shares0

Ordinary Shares

SEC:0001209191-22-004632·21 Jan 2022

Executives◇OptionsHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

05,354 shares0

Ordinary Shares

SEC:0001209191-22-004632:0·21 Jan 2022

Executives●DonHHorizon Therapeutics Public Ltd Co9SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

010,729 shares0

Ordinary Shares

SEC:0001209191-22-002285·8 Nov 2021

Executives●DonHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

010,729 shares0

Ordinary Shares

SEC:0001209191-22-002285:0·8 Nov 2021

Executives◇OptionsHHorizon Therapeutics Public Ltd Co17SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

€70,38510,729 shares@ €6.5603100.0% of flow

Ordinary Shares

SEC:0001209191-21-062085·27 Oct 2021

Executives◇OptionsHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

€70,38510,729 shares@ €6.56031.6% of flow

Ordinary Shares

SEC:0001209191-21-062085:0·27 Oct 2021

Executives●DispositionSStrongbridge Biopharma plc9SEC

S

SHERMAN JEFFREY WDirector

64,258 shares

Ordinary Shares

SEC:0001179110-21-009279·5 Oct 2021

Executives●DispositionSStrongbridge Biopharma plc11SEC

S

SHERMAN JEFFREY WDirector

64,258 shares

Ordinary Shares

SEC:0001179110-21-009279:0·5 Oct 2021

Executives◆GrantXXeris Biopharma Holdings, Inc.9SEC

S

SHERMAN JEFFREY WDirector

50,378 shares

Common Stock

SEC:0000899243-21-039322·5 Oct 2021

Executives●Retenue fiscaleSStrongbridge Biopharma plc14SEC

S

SHERMAN JEFFREY WDirector

€31,61417,763 shares@ €1.779846.2% of flow

Ordinary Shares

SEC:0001179110-21-009221·1 Oct 2021

Executives◆GrantXXeris Biopharma Holdings, Inc.11SEC

S

SHERMAN JEFFREY WDirector

50,378 shares

Common Stock

SEC:0000899243-21-039322:0·5 Oct 2021

Executives●Retenue fiscaleSStrongbridge Biopharma plc16SEC

S

SHERMAN JEFFREY WDirector

€31,61417,763 shares@ €1.779846.2% of flow

Ordinary Shares

SEC:0001179110-21-009221:0·1 Oct 2021

Executives●DonHHorizon Therapeutics Public Ltd Co9SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

04,042 shares0

Ordinary Shares

SEC:0001209191-21-057450·3 Sept 2021

Executives●DonHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

04,042 shares0

Ordinary Shares

SEC:0001209191-21-057450:0·3 Sept 2021

Executives◆GrantHHorizon Therapeutics Public Ltd Co9SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

07,257 shares0

Ordinary Shares

SEC:0001209191-21-048791·28 Jul 2021

Executives◆GrantHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

07,257 shares0

Ordinary Shares

SEC:0001209191-21-048791:0·28 Jul 2021

Executives●DonHHorizon Therapeutics Public Ltd Co9SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

066,730 shares0

Ordinary Shares

SEC:0001209191-21-045065·10 Mar 2021

Executives●DonHHorizon Therapeutics Public Ltd Co11SEC

S

SHERMAN JEFFREY WEVP and Chief Medical Officer

066,730 shares0

Ordinary Shares

SEC:0001209191-21-045065:0·10 Mar 2021

Executives◆GrantSStrongbridge Biopharma plc9SEC

S

SHERMAN JEFFREY WDirector

040,000 shares0

Ordinary Shares

SEC:0001179110-21-005557·18 May 2021

Executives◆GrantSStrongbridge Biopharma plc11SEC

S

SHERMAN JEFFREY WDirector

040,000 shares0

Ordinary Shares

SEC:0001179110-21-005557:0·18 May 2021

Executives●Retenue fiscaleSStrongbridge Biopharma plc14SEC

S

SHERMAN JEFFREY WDirector

€36,86118,944 shares@ €1.945853.8% of flow

Ordinary Shares

SEC:0001179110-21-005442·14 May 2021

Executives●Retenue fiscaleSStrongbridge Biopharma plc16SEC

S

SHERMAN JEFFREY WDirector

€36,86118,944 shares@ €1.945853.8% of flow

Ordinary Shares

SEC:0001179110-21-005442:0·14 May 2021

25 of 25 declarations

About SHERMAN JEFFREY W

Jeffrey W. Sherman is an executive at Strongbridge Biopharma plc.

Similar companies

Horizon Therapeutics Public Ltd Co

Healthcare & Pharma

Strongbridge Biopharma plc

Healthcare & Pharma

Strongbridge Biopharma plc

Healthcare & Pharma

Xeris Biopharma Holdings, Inc.

Healthcare & Pharma

Related executives

Daniel William F

Directeur Juridique